FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

787359005: Romosozumab (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3775059018 Romosozumab en Synonym Active Entire term case insensitive SNOMED CT core module
3775060011 Romosozumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Romosozumab Has disposition Sclerostin inhibitor true Inferred relationship Existential restriction modifier
Romosozumab Is a Substance with sclerostin inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier
Romosozumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing romosozumab (medicinal product) Has active ingredient True Romosozumab Inferred relationship Existential restriction modifier 1
Romosozumab Has active ingredient True Romosozumab Inferred relationship Existential restriction modifier 1
Product containing romosozumab in parenteral dose form (medicinal product form) Has active ingredient True Romosozumab Inferred relationship Existential restriction modifier 1
Product containing only romosozumab in parenteral dose form (medicinal product form) Has active ingredient True Romosozumab Inferred relationship Existential restriction modifier 1
Product containing precisely romosozumab 90 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Romosozumab Inferred relationship Existential restriction modifier 1
Product containing precisely romosozumab 90 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Romosozumab Inferred relationship Existential restriction modifier 1
Evenity 105mg/1.17ml solution for injection pre-filled pens (UCB Pharma Ltd) Has specific active ingredient True Romosozumab Inferred relationship Existential restriction modifier
Evenity 105mg/1.17ml solution for injection pre-filled pens (UCB Pharma Ltd) 2 pre-filled disposable injection Has specific active ingredient True Romosozumab Inferred relationship Existential restriction modifier
Romosozumab 105mg/1.17ml solution for injection pre-filled disposable devices Has specific active ingredient True Romosozumab Inferred relationship Existential restriction modifier
Romosozumab 105mg/1.17ml solution for injection pre-filled disposable devices 2 pre-filled disposable injection Has specific active ingredient True Romosozumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start